slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 18,554
Current window 15,721-15,750
Pages 619
Rows per page 30
Component
15,721-15,750 of 18,554
121
The slide uses a Q&A format to present expert testimony regarding alleged illegal business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
122
The slide uses a Q&A transcript format to substantiate claims of industry-wide corruption and ongoing investigations.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
123
The slide uses a Q&A transcript format to substantiate claims of kickbacks in the organ transport industry.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
125
The slide uses a legal statute to frame the company's business model as criminal activity.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
127
The slide uses a combination of narrative summary and direct excerpts from a Feb 2024 letter to expose flaws in the OPTN allocation system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
131
The slide uses a Q&A transcript format to highlight a competitor's critique of the subject company's business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
133
The slide presents a narrative of systemic corruption and regulatory bypass involving TransMedics and OPOs.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
134
The slide uses a Q&A format to document expert testimony regarding potential kickbacks and regulatory circumvention.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
135
The slide uses a Q&A format to highlight alleged unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
138
The slide presents a Q&A format with a surgeon, highlighting allegations of unethical business practices and operational friction.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
139
The slide uses a Q&A format to present testimonial evidence of alleged misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
141
The slide uses a Q&A format to highlight alleged procedural violations. The yellow highlighting emphasizes the specific claims of bypassing the OPO.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
142
Includes a Q&A transcript excerpt highlighting potential ethical/regulatory concerns regarding organ allocation and communication methods.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
144
Includes a Q&A transcript excerpt as evidence for the allegations.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
148
The slide uses a Q&A format to highlight alleged unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
149
The slide uses screenshots of the UNOS/UNet portal to establish the system's official status and legal warnings.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
150
The slide uses a Q&A transcript format to highlight potential ethical concerns regarding vendor access to sensitive medical data.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
152
The slide uses direct quotes from industry experts to build a case against TransMedics' business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
153
The slide uses a Q&A format to highlight potential misuse of system access.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
154
Includes a direct quote from an unnamed source regarding the company's technicians.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
155
The slide uses a 'fraud-exposure' framework to contrast alleged real-world usage with official FDA labeling.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
156
The slide uses a combination of qualitative expert interview summaries and quantitative data from the company's own investor presentation to frame the company's clinical claims as a 'ruse'.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
159
The slide uses Q&A transcripts to undermine a business model premise.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
162
The slide uses a Q&A format to present expert testimony regarding potential misuse of medical devices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
166
The slide uses direct quotes from UCSF hospital administrators to frame the argument that TransMedics usage is being curtailed due to cost and lack of clinical indication.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
170
The slide uses a Q&A transcript format to build a case against the clinical justification of the product's usage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
174
The slide contrasts the author's claims of widespread off-label use with the official FDA 'Indications for Use' text.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
176
The slide uses a table from a JAMA Surgery paper to highlight the mean donor age in the trial (45.9 years) as evidence of selection bias.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
177
Includes a Q&A transcript excerpt highlighting the risks of off-label use beyond the 30-minute window.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
179
The slide uses a Q&A transcript format to highlight the discrepancy between regulatory guidelines and real-world surgical behavior.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit